KCNK1 inhibits osteoclastogenesis via blocking Ca2+ oscillation/JNK-NFATc1 signaling axis

Author:

Yeon Jeong-Tae1,Kim Kwang-Jin2,Chun Sang Woo3,Lee Hae In3,Lim Ji Yeon4,Son Young-Jin2,Kim Seong Hwan4,Choi Sik-Won4

Affiliation:

1. Research Institute of Basic Science, Sunchon National University, Suncheon 540-742, Republic of Korea

2. Department of Pharmacy, Sunchon National University, Suncheon 540-742, Republic of Korea

3. Department of Oral Physiology, College of Dentistry, Institute of Wonkwang Biomaterial and Implant, Wonkwang University, Iksan 570-749, Republic of Korea

4. Laboratory of Translational Therapeutics, Pharmacology Research Center, Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 305-600, Republic of Korea

Abstract

KCNK1 (K+ channel, subfamily K, member 1) is a member of the inwardly rectifying K+ channel family driving the membrane potential towards the potassium balance potential. Here, we investigated its functional relevance to osteoclast differentiation. KCNK1 was significantly induced during osteoclast differentiation, but its functional overexpression significantly inhibited the RANKL-induced osteoclast differentiation accompanied with the attenuation of the RANKL-induced Ca2+ oscillation, JNK activation and NFATc1 expression. In contrast, KCNK1 knockdown enhanced the RANKL-induced osteoclast differentiation, JNK activation and NFATc1 expression. In conclusion, we suggested KCNK1 as a negative regulator of osteoclast differentiation; the increase of K+ influx by its functional blockade might inhibit osteoclast differentiation through inhibiting Ca2+ oscillation/JNK-NFATc1 signaling axis. Together with the increase of attention about the pharmacologic relevance of channel inhibition to the treatment of osteoclast-related disorders, further understanding for the functional roles and mechanisms of K+ channels underlying osteoclast-related diseases could be helpful to develop the relevant therapeutic strategy.

Publisher

The Company of Biologists

Subject

Cell Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3